Moringa Sponsor, LP

13D and 13G Filings

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
Silexion Therapeutics Corp 13D/A Amendment 5 SLXN · G1281K130	SLXN	G1281K130	17.7%	1,954,056	13D/A Amendment 5	9/28/2026 Event 9/18/2026
Moringa Sponsor, LP			17.7%	1,954,056
Moringa Partners Ltd			17.7%	1,954,056
Ilan Levin			17.7%	1,954,056
Silexion Therapeutics Corp 13D/A Amendment 4 SLXN · G1281K130	SLXN	G1281K130	10.6%	1,391,827	13D/A Amendment 4	8/19/2026 Event 7/30/2026
Moringa Sponsor, LP			25.0%	1,391,790
Moringa Partners Ltd			10.6%	1,391,827
Ilan Levin			10.6%	1,391,827
Silexion Therapeutics Corp 13D/A Amendment 3 SLXN · G1281K130	SLXN	G1281K130	10.6%	199,053	13D/A Amendment 3	6/23/2026 Event 6/14/2026
Moringa Sponsor, LP			10.6%	199,053
Moringa Partners Ltd			10.6%	199,053
Ilan Levin			10.6%	199,053
Silexion Therapeutics Corp 13D/A Amendment 2 SLXN · G1281K130	SLXN	G1281K130	33.0%	1,382,346	13D/A Amendment 2	5/29/2026 Event 5/14/2026
Moringa Sponsor, LP			33.0%	1,382,346
Moringa Partners Ltd			33.0%	1,382,346
Ilan Levin			33.0%	1,382,346
Silexion Therapeutics Corp 13D/A Amendment 1 SLXN · G1281K130	SLXN	G1281K130	14.7%	458,824	13D/A Amendment 1	9/23/2025 Event 9/15/2025
Moringa Sponsor, LP			14.6%	457,342
Moringa Partners Ltd			14.7%	458,824
Ilan Levin			14.7%	458,824

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.